Morgan Stanley Funds (UK) - US Advantage Fund I Accumulation GBP |
Performance History | 31/03/2025 |
Growth of 1,000 (GBP) | Advanced Graph |
![]() | Fund | -3.8 | -49.4 | 38.3 | 33.3 | -10.1 |
![]() | +/-Cat | -25.7 | -27.9 | 11.6 | 8.0 | 0.4 |
![]() | +/-B’mrk | -31.1 | -26.1 | 6.3 | -1.9 | 2.1 |
Category: US Large-Cap Growth Equity | ||||||
Category Benchmark: Morningstar US LM Brd Growt... |
Key Stats | ||
NAV 02/04/2025 | GBP 22.54 | |
Day Change | 0.40% | |
Morningstar Category™ | US Large-Cap Growth Equity | |
IA (formerly IMA) Sector | North America | |
ISIN | GB00BZ4CG750 | |
Fund Size (Mil) 02/04/2025 | GBP 58.92 | |
Share Class Size (Mil) 02/04/2025 | GBP 46.84 | |
Max Initial Charge | - | |
Ongoing Charge 17/02/2025 | 0.85% |
Morningstar Research |
Analyst Report | 03/03/2025 Robby Greengold, Principal Morningstar, Inc |
The strategy, which includes Luxembourg-domiciled MS INVF US Advantage and UK-domiciled Morgan Stanley US Advantage, can overcome its weaknesses. Its Morningstar Analyst Rating ranges from Gold to Neutral, depending on share class cost. The... | |
Click here to read this analyst report on the underlying fund. |
Morningstar Pillars | |
---|---|
People | 25 |
Parent | 23 |
Process | 24 |
Performance | |
Price |
Investment Objective: Morgan Stanley Funds (UK) - US Advantage Fund I Accumulation GBP |
The Fund aims to grow investment over 5 years or more. The Fund invests at least 80% of its assets in securities issued by US companies. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Alexander Norton 16/09/2016 | ||
Jason Yeung 16/09/2016 | ||
Click here to see others | ||
Inception Date 16/09/2016 |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
S&P 500 TR GBP | Morningstar US LM Brd Growth NR USD |
Portfolio Profile for Morgan Stanley Funds (UK) - US Advantage Fund I Accumulation GBP | 28/02/2025 |
|
|
Top 5 Holdings | Sector | % |
![]() | ![]() | 9.19 |
![]() | ![]() | 6.97 |
![]() | ![]() | 6.17 |
![]() | ![]() | 6.09 |
![]() | ![]() | 5.93 |
![]() | ||
![]() ![]() ![]() | ||
Morgan Stanley Funds (UK) - US Advantage Fund I Accumulation GBP |
Growth Of 1000 (GBP) | 31/03/2025 |
|
Annual Returns (GBP) | 31/03/2025 | |||||||
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 31/03 | |
Price Return | 5.86 | 21.91 | 68.11 | -3.76 | -49.41 | 38.32 | 33.32 | -10.12 |
+/- Category | 3.51 | -5.31 | 36.96 | -25.68 | -27.89 | 11.62 | 7.97 | 0.42 |
+/- Category Index | 1.51 | -7.42 | 36.20 | -31.11 | -26.14 | 6.29 | -1.87 | 2.09 |
% Rank in Category | 26 | 88 | 5 | 99 | 98 | 19 | 17 | 36 |
Trailing Returns (GBP) | 02/04/2025 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | 0.40 | -0.45 | -0.38 |
1 Week | -7.85 | -3.50 | -3.48 |
1 Month | -10.02 | -1.02 | -0.15 |
3 Months | -9.65 | 1.05 | 1.87 |
6 Months | 18.18 | 18.11 | 16.56 |
YTD | -9.28 | 1.42 | 2.24 |
1 Year | 13.13 | 12.22 | 7.43 |
3 Years Annualised | 3.42 | -3.14 | -5.47 |
5 Years Annualised | 8.09 | -6.75 | -10.45 |
10 Years Annualised | - | - | - |
Category: US Large-Cap Growth Equity | |||
Category Index: Morningstar US LM Brd Growth NR USD |
Quarterly Returns (GBP) | 31/03/2025 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2025 | -10.12 | - | - | - |
2024 | 8.71 | -8.00 | 2.94 | 29.51 |
2023 | 13.17 | 12.81 | -7.61 | 17.27 |
2022 | -22.29 | -32.82 | 12.53 | -13.89 |
2021 | -6.53 | 13.57 | -3.94 | -5.62 |
2020 | -1.72 | 40.39 | 10.53 | 10.23 |
Morningstar Rating™(Relative to Category) | 28/02/2025 | ||||||||||||||||||||
| |||||||||||||||||||||
Category : US Large-Cap Growth Equity | Click here to see our Methodology |
Volatility Measurements | 31/03/2025 | ||||||||||
| |||||||||||
Modern Portfolio Statistics | 31/03/2025 | 31/03/2025 |
Standard Index | Best Fit Index | |
Morningstar US LM Brd Growth NR USD | FTSE Global CB TR USD | |
3-Yr Beta | 1.17 | 2.26 |
3-Yr Alpha | -4.27 | 7.49 |
Investment Style Details | 28/02/2025 | ||||||||||||||||||||||||||||||||||||||||
|
| ||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||
Category: US Large-Cap Growth Equity |
Asset Allocation | 28/02/2025 |
|
World Regions | 28/02/2025 | ||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||
Category: US Large-Cap Growth Equity |
Sector Weightings | 28/02/2025 | ||||||||||||||||||||||||
| |||||||||||||||||||||||||
Category: US Large-Cap Growth Equity |
Top 10 Holdings | 28/02/2025 |
Portfolio NEW | |
Total Number of Equity Holdings | 25 |
Total Number of Bond Holdings | 0 |
Assets in Top 10 Holdings | 56.37 |
Name | Sector | Country | % of Assets | ||
![]() | ![]() | United States | 9.19 | ||
![]() | ![]() | United States | 6.97 | ||
![]() | ![]() | Canada | 6.17 | ||
![]() | ![]() | United States | 6.09 | ||
![]() | ![]() | Brazil | 5.93 | ||
![]() | ![]() | United States | 4.71 | ||
![]() | ![]() | United States | 4.65 | ||
![]() | ![]() | United States | 4.51 | ||
![]() | ![]() | United States | 4.08 | ||
![]() | ![]() | Netherlands | 4.07 | ||
![]() ![]() ![]() | |||||
Category: US Large-Cap Growth Equity | |||||
Management | ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
|
![]() | |
Biography | |
Alexander Norton is an investor for the Counterpoint Global team. He joined Morgan Stanley in 2000 and has been with financial industry since 1995. Prior to joining the firm, Alex was an associate in equity derivative sales and later an associate in equity research at Donaldson, Lufkin & Jenrette. Previously, he was a bond broker with Cantor Fitzgerald. Alex received a B.A. in history from the University of Pennsylvania and an M.B.A. in finance from Columbia Business School. |
![]() |
Fund Manager | Jason Yeung |
Manager Start Date | 16/09/2016 |
Career Start Year | 1997 |
Education |
University of Cambridge, M.A. |
Johns Hopkins University, B.A. |
![]() | |
Biography | |
Jason Yeung is an investor for the Counterpoint Global team. He joined Morgan Stanley in 2002 and has been with financial industry since 1997. Jason joined the team in 2004 as an investor. Previously, he was a member of the U.S. Research Group, working closely with the Counterpoint Global team. Prior to joining the firm, Jason was a senior research analyst at Ramius Capital Group. Previously, he was an equity research associate at Deutsche Bank. Jason received a B.A., Phi Beta Kappa, in international relations from Johns Hopkins University and an M. Phil. in international relations from the University of Cambridge. He holds the Chartered Financial Analyst designation. |
![]() |
Fund Manager | Armistead Nash |
Manager Start Date | 16/09/2016 |
Career Start Year | 2000 |
Education |
University of Virginia (Darden), M.B.A. |
University of Virginia, B.A. |
![]() | |
Biography | |
Armistead Nash is an investor for the Counterpoint Global team. He joined Morgan Stanley in 2002 and has has been with financial industry since 2000. Armistead joined the team in 2004 as an investor. Previously, he was a member of the U.S. Research Group, working closely with the Counterpoint Global team. Prior to joining the firm, Armistead was an associate in investment product development at BlackRock Financial Management. Previously, he was a research analyst in high-yield research at KEA Capital. Armistead received a B.A. in history from the University of Virginia and an M.B.A. from the University of Virginia's Darden School of Business Administration. |
![]() |
Fund Manager | Dennis Lynch |
Manager Start Date | 16/09/2016 |
Career Start Year | 1994 |
Education |
Hamilton College, B.A. |
Columbia University, M.B.A. |
![]() | |
Biography | |
Dennis is the Head of the Counterpoint Global team at Morgan Stanley Investment Management. He joined Morgan Stanley in 1998 and has been with financial industry since 1994. Prior to joining the firm, he worked as a sell-side analyst for J.P. Morgan Securities. Dennis received a B.A. in political science from Hamilton College and an M.B.A. with honors in finance from Columbia University. |
![]() |
Fund Manager | David Cohen |
Manager Start Date | 16/09/2016 |
Career Start Year | 1988 |
Education |
1999, Pace University, B.S. |
![]() | |
Biography | |
Dave Cohen is an investor for the Counterpoint Global team. He joined Morgan Stanley in 1993 and has has been with financial industry since 1988. Dave joined the team as an investor in 1999. Prior to joining the firm, Dave was a senior fund accountant at Alliance Capital. Previously, he was a fund accountant at Natwest and Wall Street Trust. Dave received a B.S. summa cum laude in management from Pace University. |
![]() |
Fund Manager | Sandeep (Sam) Chainani |
Manager Start Date | 16/09/2016 |
Career Start Year | 1996 |
Education |
1996, Binghamton University, B.S. |
![]() | |
Biography | |
Sam Chainani is an investor for the Counterpoint Global team. He joined Morgan Stanley in 1996 and has been with financial industry since 1996. Sam joined the team as an investor in 2000. Previously, he was a strategy specialist for our Inception and Discovery strategies. Sam received a B.S. in management with a concentration in finance from Binghamton University. He holds the Chartered Financial Analyst designation. |
Fees and Expenses | ||||||||||||
|
Purchase Details | ||||||||
| ||||||||
|